Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2009 | |
| Sales | 210,461 | 229,681 | 204,323 | 118,356 | 84,011 |
| Cost of Goods | 159,205 | 142,725 | 114,020 | 90,252 | 36,204 |
| Gross Profit | 51,256 | 86,956 | 90,303 | 28,104 | 47,807 |
| Operating Expenses | 69,444 | 70,191 | 64,926 | 61,901 | 13,311 |
| Operating Income | -17,983 | 17,490 | 25,397 | -33,545 | 34,700 |
| Interest Expense | 609 | 958 | 784 | 584 | 0 |
| Other Income | 444 | 695 | 1,265 | 2,242 | 0 |
| Pre-tax Income | -18,148 | 17,227 | 25,878 | -31,887 | 34,700 |
| Income Tax | -7,449 | 5,365 | 7,784 | -39,639 | 11,835 |
| Net Income Continuous | -10,699 | 11,862 | 18,094 | 7,752 | 22,865 |
| Net Income | $-10,699 | $11,862 | $18,094 | $7,752 | $22,865 |
| EPS Basic Total Ops | -0.25 | 0.31 | 0.47 | 0.20 | N/A |
| EPS Basic Continuous Ops | -0.26 | 0.31 | 0.47 | 0.20 | N/A |
| EPS Diluted Total Ops | -0.25 | 0.31 | 0.46 | 0.20 | N/A |
| EPS Diluted Continuous Ops | -0.26 | 0.31 | 0.46 | 0.20 | N/A |
| EBITDA(a) | $-3,535 | $30,568 | $36,894 | $-22,395 | $34,700 |